Larimar Therapeutics Files 2024 10-K
Ticker: LRMR · Form: 10-K · Filed: Mar 24, 2025 · CIK: 1374690
| Field | Detail |
|---|---|
| Company | Larimar Therapeutics, Inc. (LRMR) |
| Form Type | 10-K |
| Filed Date | Mar 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceutical, financials
TL;DR
Larimar Therapeutics filed its 2024 10-K, check financials and strategy.
AI Summary
Larimar Therapeutics, Inc. filed its 2024 10-K on March 24, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Zafgen, Inc., is involved in pharmaceutical preparations. The filing details its financial performance and business operations, including information on its equity incentive plan and leasehold improvements.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Larimar Therapeutics' financial health and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Larimar Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-24 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Larimar Therapeutics, Inc. (company) — Filer
- Zafgen, Inc. (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 2025-03-24 (date) — Filing date
- Three Bala Plaza East, Suite 506 (address) — Business and mailing address
- 844-511-9056 (phone_number) — Business phone number
FAQ
What was Larimar Therapeutics' former company name?
Larimar Therapeutics, Inc. was formerly known as Zafgen, Inc.
On what date was the 2024 10-K filing submitted?
The 2024 10-K filing was submitted on March 24, 2025.
What is the fiscal year end for this filing?
The fiscal year end for this filing is December 31, 2024.
What is Larimar Therapeutics' business address?
Larimar Therapeutics' business address is Three Bala Plaza East, Suite 506, Bala Cynwyd, PA 19004.
What is the SIC code for Larimar Therapeutics?
The Standard Industrial Classification (SIC) code for Larimar Therapeutics is 2834, Pharmaceutical Preparations.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 24, 2025 regarding Larimar Therapeutics, Inc. (LRMR).